Tuesday, March 19, 2024

Partner Profiles

AccuTOX®

Defence Therapeutics granted US patent for AccuTOX® technology

Defence Therapeutics has achieved a significant milestone with the granting of US patent no. 11,890,350 ('350) by the United States Patent and Trademark Office...
drug delivery

BioNxt acquires cutting-edge equipment to boost drug delivery product manufacturing

BioNxt Solutions Inc. has proudly announced the acquisition of advanced coating and cutting equipment, marking a crucial stride in expanding its commercial manufacturing of...
lung tumours

Defence Therapeutics’ breakthrough in cancer treatment: AccuTOX® shows promise against lung tumours

Defence Therapeutics has announced the successful testing of a new formulation of its ACCUM-002TM Dimer CDCA-SV40 against lung tumours.


Pin It on Pinterest